Focal Segmental Glomerulosclerosis
Unclear etiology, and complex pathogenesis; poor understanding of Focal Segmental Glomerulosclerosis remains a significant unmet need in the market
Focal Segmental Glomerulosclerosis

More Whitepapers / Newsletters

An Abundance Of Rare Newsletter
An Abundance Of Rare

Though appear rare, rare diseases are far from being rare. With over 7,000 rare disease affecting millions worldwide, Rare disease pose a huge burden on the global healthcare system, affecting the qua...

COVID-19 Whitepaper

Over the last months, the world has faced one of the most unexpected challenges in the form of a novel coronavirus, SARS-CoV-2, infection. Through the whitepaper, DelveInsight aims to make its clients...

Schizophrenia Market

Schizophrenia is a severe mental illness that interferes with a person's ability to think clearly, manage emotions, make decisions, and relate to others. It is a complex, long-term medical illness, af...

Systemic Scleroderma Market
Systemic Scleroderma

Systemic scleroderma (SSC or systemic sclerosis) is an autoimmune disorder that results into scar tissues (fibrosis) on the skin and internal organs. The prevalence of systemic scleroderma is about 30...

Remdesivir In COVID-19
Remdesivir In COVID-19

Remdesivir is a broad-spectrum antiviral drug that has previously demonstrated in vitro and in vivo activity against the viral pathogens MERS and SARS, which are also coronaviruses having structural s...